World's Best Scientists 2026 revealed!
Hiroaki Shimokawa

Hiroaki Shimokawa

Award Badge
Medicine
Japan
2023

D-Index & Metrics

Medicine

D-Index
143
Citations
85882
World Ranking
1500
National Ranking
28

Hiroaki Shimokawa publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Hiroaki Shimokawa sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 1,566 publications — 99th percentile

99% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Hiroaki Shimokawa D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Hiroaki Shimokawa sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 143 D-Index — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2023 - Research.com Medicine in Japan Leader Award

Overview

Hiroaki Shimokawa is affiliated with Tohoku University in Japan and has a significant body of research in the field of medicine, with a strong focus on cardiology and cardiovascular medicine. Their work spans multiple subfields including cardiology and cardiovascular medicine, radiology, nuclear medicine and imaging, surgery, pulmonary and respiratory medicine, and physiology.

The primary research topics covered by Hiroaki Shimokawa include:

  • Cardiac Imaging and Diagnostics
  • Cardiovascular Function and Risk Factors
  • Coronary Interventions and Diagnostics
  • Heart Failure Treatment and Management
  • Lipoproteins and Cardiovascular Health
  • Cardiac Electrophysiology and Arrhythmias
  • Atrial Fibrillation Management and Outcomes

Among recent published papers, notable examples include:

  • Clinical characteristics and prognosis of patients with microvascular angina: an international and prospective cohort study by the Coronary Vasomotor Disorders International Study (COVADIS) Group, 2021, European Heart Journal
  • Treatment of coronary microvascular dysfunction, 2020, Cardiovascular Research
  • Assessment of Vascular Dysfunction in Patients Without Obstructive Coronary Artery Disease, 2020, JACC: Cardiovascular Interventions
  • JCS/CVIT/JCC 2023 Guideline Focused Update on Diagnosis and Treatment of Vasospastic Angina (Coronary Spastic Angina) and Coronary Microvascular Dysfunction, 2023, Circulation Journal
  • Coronary Microvascular Dysfunction, 2021, Arteriosclerosis Thrombosis and Vascular Biology

Hiroaki Shimokawa has collaborated frequently with a range of co-authors, including:

  • Satoshi Yasuda
  • Jun Takahashi
  • Kotaro Nochioka
  • Satoshi Miyata
  • Takashi Shiroto

The scientist's work has been published in several prominent academic journals, particularly:

  • European Heart Journal
  • International Journal of Cardiology
  • IJC Heart & Vasculature
  • SSRN Electronic Journal
  • Arteriosclerosis Thrombosis and Vascular Biology

This research spans a broad range of cardiovascular-related medical topics and diagnostic techniques, indicating integrative expertise in clinical cardiology. While no awards or book publications are recorded, the scope and frequent citations of their work reflect an active research profile within cardiovascular medicine.

Best Publications

  • Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

    Paul M Ridker;Brendan M. Everett;Tom Thuren;Jean G. MacFadyen

  • Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

    Paul M Ridker;Jean G MacFadyen;Tom Thuren;Brendan M Everett

  • International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology

    Jelena Rima Ghadri;Ilan Shor Wittstein;Abhiram Prasad;Scott Sharkey

  • Heart failure: preventing disease and death worldwide.

    Piotr P. Ponikowski;Stefan D. Anker;Khalid F. AlHabib;Martin R. Cowie

  • Endothelial dysfunction and vascular disease

    P. M. Vanhoutte;H. Shimokawa;E. H. C. Tang;M. Feletou

  • The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation.

    Hiroaki Shimokawa;Hiroshi Yasutake;Koji Fujii;M. Owada

  • Endothelial dysfunction and vascular disease – a 30th anniversary update

    P. M. Vanhoutte;H. Shimokawa;M. Feletou;E. H. C. Tang

  • Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial

    Paul M Ridker;Jean G MacFadyen;Brendan M Everett;Peter Libby

  • Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice

    Tetsuya Matoba;Hiroaki Shimokawa;Mikio Nakashima;Yoji Hirakawa

  • Double-blind and placebo-controlled study of the effectiveness and safety of extracorporeal cardiac shock wave therapy for severe angina pectoris.

    Yoku Kikuchi;Kenta Ito;Yoshitaka Ito;Takashi Shiroto

  • Extracorporeal cardiac shock wave therapy improves left ventricular remodeling after acute myocardial infarction in pigs

    Toyokazu Uwatoku;Kenta Ito;Kohtaro Abe;Keiji Oi

  • Cardiac shock wave therapy ameliorates left ventricular remodeling after myocardial ischemia-reperfusion injury in pigs in vivo.

    Yoshitaka Ito;Kenta Ito;Takashi Shiroto;Ryuji Tsuburaya

  • International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management

    Jelena Rima Ghadri;Ilan Shor Wittstein;Abhiram Prasad;Scott Sharkey

  • Rho-Kinase Is an Important Therapeutic Target in Cardiovascular Medicine

    Hiroaki Shimokawa;Akira Takeshita

  • Long-Term Inhibition of Rho-Kinase Suppresses Angiotensin II–Induced Cardiovascular Hypertrophy in Rats In Vivo Effect on Endothelial NAD(P)H Oxidase System

    Midoriko Higashi;Hiroaki Shimokawa;Tsuyoshi Hattori;Junko Hiroki

  • Suppression of Coronary Artery Spasm by the Rho-Kinase Inhibitor Fasudil in Patients With Vasospastic Angina

    Akihiro Masumoto;Masahiro Mohri;Hiroaki Shimokawa;Lemmy Urakami

  • International standardization of diagnostic criteria for microvascular angina.

    Peter Ong;Paolo G. Camici;John F. Beltrame;Filippo Crea

  • Rho-Kinase Mediates Hypoxia-Induced Downregulation of Endothelial Nitric Oxide Synthase

    Masao Takemoto;Jianxin Sun;Junko Hiroki;Hiroaki Shimokawa

  • Primary endothelial dysfunction: Atherosclerosis

    Hiroaki Shimokawa

  • Long-Term Treatment With a Rho-Kinase Inhibitor Improves Monocrotaline-Induced Fatal Pulmonary Hypertension in Rats

    Kohtaro Abe;Hiroaki Shimokawa;Keiko Morikawa;Toyokazu Uwatoku

Frequent Co-Authors

Akira Takeshita
Akira Takeshita Kyushu University
Kensuke Egashira
Kensuke Egashira Kyushu University
Nobuyuki Yanagihara
Nobuyuki Yanagihara University of Occupational and Environmental Health Japan
Hisao Ogawa
Hisao Ogawa Kumamoto University
Paul M. Vanhoutte
Paul M. Vanhoutte University of Hong Kong
Akira Ito
Akira Ito Nagoya University
Kozo Kaibuchi
Kozo Kaibuchi Nagoya University
Kenji Sunagawa
Kenji Sunagawa Kyushu University
Hiroyuki Tsutsui
Hiroyuki Tsutsui Kyushu University
Hiroshi Kanai
Hiroshi Kanai Tohoku University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students considering a future in medicine but looking for flexible or alternative educational routes, numerous online degrees open up diverse healthcare careers. For example, those interested in nutrition and wellness can explore the best online nutrition degree programs, which provide a solid foundation in dietetics and public health.

Aspiring healthcare administrators can pursue online mha programs cahme accredited, ensuring they meet rigorous industry standards for leadership roles in hospitals or clinics. For nursing professionals, there are pathways such as rn to bsn no clinical hours, which offer practicing RNs the chance to obtain a bachelor’s degree online without additional hands-on requirements.

Those looking to advance quickly into leadership or specialized nursing roles should consider accelerated dnp programs, designed to fast-track experienced nurses toward a Doctor of Nursing Practice. These flexible options allow students to build their careers in healthcare without the limitations of traditional, on-campus programs.

Best Scientists Citing Hiroaki Shimokawa

Trending Scientists

Recently Published Articles